Bruker (BRKR) Payables (2010 - 2026)

Bruker's Payables history runs 17 years deep, the most recent figure standing at $269.1 million for Q1 2026.

• Quarterly Payables rose 10.02% year-over-year to $269.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $269.1 million (up 10.02% YoY) and the FY2025 annual result came in at $266.5 million, up 13.4% from the prior year.
• Payables was $269.1 million for Q1 2026 at Bruker, up from $266.5 million in the prior quarter.
• Across five years, Payables topped out at $269.1 million in Q1 2026 and bottomed at $154.9 million in Q2 2022.
• A 5-year average of $206.6 million and a median of $199.1 million in 2024 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables climbed 25.34% — and 2025, when it slipped 18.95%.
• Bruker's Payables stood at $179.3 million in 2022, then advanced by 13.55% to $203.6 million in 2023, then climbed by 15.42% to $235.0 million in 2024, then advanced by 13.4% to $266.5 million in 2025, then advanced by 0.98% to $269.1 million in 2026.
• Business Quant data shows BRKR's Payables at $269.1 million in Q1 2026, $266.5 million in Q4 2025, and $184.4 million in Q3 2025.